Biopolis – The Biotechnology Cluster of Singapore
Owing to the success of Liftstream’s biotech cluster reviews and the rapid growth of its corresponding group on Linkedin. Liftstream has profiled Biopolis, the biotechnology cluster of Singapore. Singapore has established itself as a leading biotechnology cluster in not only the Asian but Global biotechnology market. Biopolis has attracted a host of international pharmaceutical companies as well as a significant number of local start-up biotech companies.
Bluebird bio sings to tune of $9.3m as gene therapy shows promise
Shire Pharmaceuticals CEO, Angus Russell, announces departure and sucessor
FTSE Females Falter but Diversity on course
The Market Access Challenge for Orphan Drugs
Authored by Paul Foster
European Society for Medical Oncology (ESMO) Congress 2012 Highlights
The European Society for Medical Oncology (ESMO) recently held its annual congress in Vienna, Austria. The congress was a flood with a variety of new and updated clinical data about a number of cancer drugs currently in development. The congress was a blend of big pharma and small innovative biotech’s presenting a wide array of data. Below, Liftstream looks at some of the highlights from the congress.
Rare Disease Year in Review
This year has been a tumultuous year for the rare diseases market with a number of significant news stories revolving around M&A rumours, regulatory approvals, IPO’s, investments and partnering agreements. Liftstream takes a look at these events: